GGrantIndex
Sort

53,477 grants matching addiction

Leveraging regulatory flexibility for methadone take-home dosing to improve retention in treatment for opioid use disorder: A stepped-wedge randomized trial to facilitate clinic level changes

$1,146,095
Charles J Neighbors · New York University School Of Medicine · R33 · FY2023 · DA

Phase 1 safety-interaction study of pomaglumetad methionil for methamphetamine use disorder

$1,145,783
Keith Gregory Heinzerling · University Of California Los Angeles · R01 · FY2017 · DA

Clinical Trials Network: Pacific Northwest Node

$1,145,494
Dennis M Donovan · University Of Washington · U10 · FY2010 · DA

Genetics of Cocaine Dependence

$1,145,427
Joel Gelernter · Yale University · R01 · FY2008 · DA

MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE. PERIOD OF PERFORMANCE: 7/10/2019-7/9/2020. N01DA-19-8949

$1,145,375
Patrick Beardsley · Virginia Commonwealth University · N01 · FY2019 · DA

HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium

$1,144,969
Carla M Bann · Research Triangle Institute · U24 · FY2024 · HD

Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings

$1,144,825
Frederick Lewis Altice · Yale University · R01 · FY2025 · DA

Clinical Trials Network Mid-Atlantic Collaborative Group

$1,144,797
Maxine L Stitzer · Johns Hopkins University · U10 · FY2015 · DA

The National Drug Abuse Treatment Clinical Trials Network

$1,144,584
Roger D. Weiss · Mclean Hospital · UG1 · FY2019 · DA

Center for Study of Opioid Receptors and Drugs of Abuse (CSORDA)

$1,144,265
Christopher J Evans · University Of California Los Angeles · P50 · FY2008 · DA

12/24 Healthy Brain and Child Development National Consortium

$1,144,186
Elinor L. Sullivan · Oregon Health & Science University · U01 · FY2023 · DA

Preventing Substance Use in the Context of Poverty: Risk and Protection from Early Childhood to Early Adulthood

$1,143,830
Daniel S Shaw · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$1,143,747
James L. Sorensen · University Of California, San Francisco · U10 · FY2010 · DA

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)

$1,143,049
Karen L Cropsey · University Of Alabama At Birmingham · P01 · FY2023 · AA

Alternative Therapies for Alcohol and Drug Abuse

$1,142,933
David Yue-Wei Lee · Mclean Hospital · P01 · FY2006 · AT

A Comparative Framework for Modeling the Low-Dimensional Geometry of Neural Population States

$1,142,747
Eva Dyer · Georgia Institute Of Technology · R01 · FY2020 · EB

Sex Differences and Progesterone Effects on Impulsivity, Smoking & Cocaine Abuse

$1,142,594
Marilyn E. Carroll · University Of Minnesota · P50 · FY2015 · DA

SCOR Application on Sex, Stress, and Cocaine Addiction

$1,141,784
Yale University · P50 · FY2005 · DA

TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES

$1,141,431
Mary J Kreek · Rockefeller University · P60 · FY2012 · DA

Dopamine Receptor Proteomics

$1,140,476
David Sibley · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS

Novel interventions to reduce stress induced non-homeostatic eating

$1,140,318
Elissa S. Epel · University Of California, San Francisco · U01 · FY2010 · HL

HEALthy Brain and Child Development Study at UAB and UA

$1,140,130
A. Myriam Peralta-Carcelen · University Of Alabama At Birmingham · U01 · FY2021 · DA

GENETICS OF VULNERABILITY TO NICOTINE ADDICTION

$1,140,000
Washington University · R01 · FY2000 · DA

Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study

$1,139,906
Emily Ai-Hua Wang · Yale University · UG1 · FY2022 · DA

ADDICTIONS: GENOTYPES, POLYMOPHISMS, AND FUNCTION

$1,139,630
Rockefeller University · R01 · FY2003 · DA